Clinical Trials
6 trialsNCT05415215 2026-02-10
ProHer
Hoffmann-La Roche
Phase 3 Completed
NCT04660929 2024-12-18
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Unknown
NCT03184558 2021-11-09
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
BerGenBio ASA
Phase 2 Terminated
NCT00105950 2015-09-28
Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer
GlaxoSmithKline
Phase 2 Completed
NCT00558103 2013-02-04
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
GlaxoSmithKline
Phase 2 Completed
NCT00891280 2011-06-15
Dose-escalation Study of Oral CX-4945
Cylene Pharmaceuticals
Phase 1 Unknown